Boston, Massachusetts, United States
At Elephas we are working every day to help improve the lives of cancer patients by developing a novel platform that will predict response to immunotherapy in 72 hours. As the Chief Commercial Officer, I am working with the teams to develop and commercialize the Elephas Live Platform - which will identify who will respond to immunotherapy, ex vivo, using a patient’s live tumor. Leveraging a proven track record of launching innovative devices, diagnostics and pharmaceuticals, I bring a culture of collaboration, creativity and excellence to every interaction. Prior to Elephas, I was the Chief Growth Officer at Precision AQ, a prominent life sciences services firm. During my 20-year tenure at Precision AQ, I managed multiple P&Ls, led teams across various geographies, and oversaw numerous acquisitions both in the US and internationally. My expertise lies in identifying growth opportunities and swiftly activating teams and strategies to maximize potential.